Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD



Status:Completed
Conditions:Anxiety, Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:7 - 12
Updated:11/14/2018
Start Date:August 1, 2017
End Date:May 31, 2018

Use our guide to learn which trials are right for you!

Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders

Cognitive Behavioral Therapy with fear provoking exposures is the most effective therapy for
anxiety disorders. Investigators aim to enhance this therapy with the use of virtual reality
exposures and to make therapy more available and accessible for patients with anxiety
disorders. The societal benefit of increased access to therapy is that, if successful, it
will increase the number of patients who receive appropriate treatment for an anxiety
disorder.

Twenty children with CADs or OCD who have received less than 3 treatment sessions and a
parent will be recruited to pilot the VR system. Participants will be identified through the
Mayo Clinic Pediatric Anxiety Disorders Clinic. Each patient will participate in a single (up
to) 2-hour visit. During the first 30 minutes the patient and parent will be introduced to
the VR system and the rationale for this feasibility study. Next, a therapist will lead the
patient through exposure exercises using the VR system for up to 30 minutes. During the next
period, up to 30 minutes, the therapist will go to a different room and the patient, with
support from their parent, will complete exposure exercises using the VR system that the
therapist directed them to complete. During the exposures the interviewer will observe, code
and record the patient's interaction with the VR system. For the remaining time (up to 30
minutes) the interviewer will interview the patient about his or her experience with the VR
system and then will ask for observations and opinions from the parent.

Inclusion Criteria:

1. Age 7 to 12

2. Primary diagnosis of anxiety, generalized anxiety disorder, social phobia, separation
anxiety and/or OCD

Exclusion Criteria:

1. History of and/or current diagnosis of: psychosis, autism, bipolar disorder, mental
retardation, oppositional defiant disorder, PTSD, selective mutism or major depressive
disorder.

2. Current suicidality or recent suicidal behavior

3. Parent to be involved in study who is unable to adequately participate due to
intellectual or psychiatric difficulties

4. Starting or changing the dosage of a psychiatric medication in the last 2 months
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials